SenzaGen’s Newsletter Q1 2026
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q1, 2026 SOT 2026: Advancing NAMs for skin and respiratory sensitization testing We had a fantastic time at […]
This author has not written his bio yet.
But we are proud to say that Julia Li contributed 67 entries already.
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q1, 2026 SOT 2026: Advancing NAMs for skin and respiratory sensitization testing We had a fantastic time at […]
Advancing quantitative NAMs for skin sensitization risk assessment – Collaborative work within IDEA QRA-NAMs Working Group A new article published in Regulatory Toxicology and Pharmacology presents the outcomes of collaborative work within the […]
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q4, 2025 As 2025 draws to a close: This quarter caps a year of significant progress in advancing […]
Click image to view the Newsletter in browser. Safe dose levels for sensitizers, NESIL values for HRIPT, and PoD-based QRA Skin sensitization potency assessment has been in the spotlight at […]
Supporting industry decision-making and hypoallergenicity claims using an experimental setup combining GARD®skin Medical Device and Dose-Response protocols. Presented at 2025 Eurotox Download a copy in PDF Conclusion This case […]
In vitro skin sensitization potency assessment using GARD®skin Dose-Response: A case study on natural extracts-based skin-binding dyes and dye precursors Presented at 2025 Eurotox Download a copy in PDF […]
Comparative analysis of skin sensitization thresholds for Essential Oils: Human, murine, and GARD®skin Dose-Response Presented at 2025 Eurotox Download a copy in PDF Conclusion NESIL predictions from GARD® were […]
